Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
Clinical trial NCT00005618 · COMPLETED
Trial details
- NCT number
- NCT00005618
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.